ATE445011T1 - Hemopoietin-rezeptor und dafür kodierende genetische sequenzen - Google Patents

Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Info

Publication number
ATE445011T1
ATE445011T1 AT96934193T AT96934193T ATE445011T1 AT E445011 T1 ATE445011 T1 AT E445011T1 AT 96934193 T AT96934193 T AT 96934193T AT 96934193 T AT96934193 T AT 96934193T AT E445011 T1 ATE445011 T1 AT E445011T1
Authority
AT
Austria
Prior art keywords
genetic sequences
receptor
sequences coding
hemopoietin receptor
components
Prior art date
Application number
AT96934193T
Other languages
English (en)
Inventor
Tracy Willson
Nicos Nicola
Douglas Hilton
Donald Metcalf
Jian Zhang
Original Assignee
Zenyth Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27157889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE445011(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AUPN6135A external-priority patent/AUPN613595A0/en
Priority claimed from AUPN7276A external-priority patent/AUPN727695A0/en
Priority claimed from AUPO2208A external-priority patent/AUPO220896A0/en
Application filed by Zenyth Operations Pty Ltd filed Critical Zenyth Operations Pty Ltd
Application granted granted Critical
Publication of ATE445011T1 publication Critical patent/ATE445011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compression, Expansion, Code Conversion, And Decoders (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96934193T 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen ATE445011T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN6135A AUPN613595A0 (en) 1995-10-23 1995-10-23 A novel haemopoietin receptor and genetic sequences encoding same
AUPN7276A AUPN727695A0 (en) 1995-12-22 1995-12-22 A novel haempoietin receptor and genetic sequences encoding same - II
AUPO2208A AUPO220896A0 (en) 1996-09-09 1996-09-09 A novel haemopoietin receptor and genetic sequences encoding same - III
PCT/AU1996/000668 WO1997015663A1 (en) 1995-10-23 1996-10-23 A novel haemopoietin receptor and genetic sequences encoding same

Publications (1)

Publication Number Publication Date
ATE445011T1 true ATE445011T1 (de) 2009-10-15

Family

ID=27157889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934193T ATE445011T1 (de) 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Country Status (8)

Country Link
EP (1) EP0907730B1 (de)
JP (2) JP4224135B2 (de)
AT (1) ATE445011T1 (de)
AU (1) AU718899C (de)
CA (1) CA2238080C (de)
DE (1) DE69638050D1 (de)
ES (1) ES2334408T3 (de)
WO (1) WO1997015663A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
US6703488B1 (en) * 1998-01-15 2004-03-09 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
NZ512942A (en) 1998-12-14 2004-01-30 Univ Johns Hopkins Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
WO2000075314A1 (fr) 1999-06-02 2000-12-14 Chugai Research Institute For Molecular Medicine, Inc. Proteine receptrice d'hemopoietine
WO2001023556A1 (fr) 1999-09-27 2001-04-05 Chugai Seiyaku Kabushiki Kaisha Nouvelle proteine receptrice d'hemopoietine (nr12)
AU2003212102B2 (en) * 2002-03-22 2010-01-14 Zenyth Operations Pty Ltd Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
WO2003080675A2 (en) * 2002-03-22 2003-10-02 Amrad Operations Pty Ltd MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1)
EP1703893B1 (de) 2003-12-23 2012-04-11 Genentech, Inc. Neue anti-il 13-antikörper und verwendungen dafür
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
EP1824886B1 (de) 2004-11-17 2010-12-22 Amgen Inc. Vollständige humane monoklonale antikörper gegen il-13
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
KR101557603B1 (ko) 2006-06-08 2015-10-06 추가이 세이야쿠 가부시키가이샤 염증성 질환의 예방 또는 치료제
US8207304B2 (en) 2006-10-19 2012-06-26 Csl Limited Antibody antagonists of interleukin-13 receptor α1
PL2068921T3 (pl) 2006-10-19 2014-12-31 Csl Ltd Przeciwciała o dużym powinowactwie będące antagonistami receptora alfa1 interleukiny 13
EP2068922B1 (de) 2006-10-19 2012-06-27 CSL Limited Anti-il-13r-alpha-1-antikörper und ihre verwendung
BRPI0821145B8 (pt) 2007-12-05 2021-05-25 Chugai Pharmaceutical Co Ltd uso de um anticorpo anti-nr10 como agente preventivo ou terapêutico para prurido
ES2532483T3 (es) 2007-12-15 2015-03-27 F. Hoffmann-La Roche Ag Ensayo de distinción
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
CA3184564A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
KR102332302B1 (ko) 2013-09-13 2021-12-01 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
WO2020106704A2 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
KR20210143788A (ko) 2019-03-26 2021-11-29 아슬란 파마슈티컬스 피티이 엘티디 항-il-13r 항체 또는 이의 결합 단편을 이용하는 치료
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2022186772A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2022186773A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
WO2023048651A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd Method for treatment of moderate to severe atoptic dematitis
WO2023048650A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
TW202333784A (zh) 2021-10-29 2023-09-01 新加坡商亞獅康私人有限公司 抗ｉｌ１３ｒ抗體調配物
WO2024043837A1 (en) 2022-08-26 2024-02-29 Aslan Pharmaceuticals Pte Ltd High concentration anti-il13r antibody formulation
WO2024054157A1 (en) 2022-09-06 2024-03-14 Aslan Pharmaceuticals Pte Ltd Treatment for sleep loss or sleep disturbance in patients with dermatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
WO1996007737A1 (en) * 1994-09-05 1996-03-14 Amrad Operations Pty. Ltd. A novel haemopoietin receptor
WO1996011213A1 (en) * 1994-10-07 1996-04-18 Amgen Boulder Inc. Dimeric il-4 inhibitors
FR2742156A1 (fr) * 1995-12-06 1997-06-13 Sanofi Sa Polypeptide recepteur de l'il-13

Also Published As

Publication number Publication date
JP4224135B2 (ja) 2009-02-12
DE69638050D1 (de) 2009-11-19
AU718899B2 (en) 2000-04-20
AU718899C (en) 2004-01-29
CA2238080A1 (en) 1997-05-01
CA2238080C (en) 2012-03-13
EP0907730B1 (de) 2009-10-07
AU7266896A (en) 1997-05-15
JP2008029340A (ja) 2008-02-14
EP0907730A4 (de) 2001-11-07
JPH11514873A (ja) 1999-12-21
WO1997015663A1 (en) 1997-05-01
ES2334408T3 (es) 2010-03-09
EP0907730A1 (de) 1999-04-14

Similar Documents

Publication Publication Date Title
ATE445011T1 (de) Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
DE69918946D1 (de) Rezeptoren für il-18
CY1112101T1 (el) Νευροτροφικοι παραγοντες
DE69131249T2 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
PT1015586E (pt) Homologos de ligandos do receptor tirosina-quinase tie
ATE309375T1 (de) Onkostatin- m rezeptor
PT915974E (pt) Ligandos de receptores de tie-2 modificados
SE9301755D0 (sv) A method of determining affinity and kinetic properties
DE69428689T2 (de) Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer
ID1044B (id) Antibodi terubah dan pembuatannya
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
DE69535831D1 (de) Hemopoietin-rezeptor
ATE252158T1 (de) Nicht-nukleotid verknüpfende reagentien
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
DE60031576D1 (en) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
DE69935782D1 (de) Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
TR199701469T1 (xx) �i�man (OB) proteinin etkilerini de�i�tiren bile�imlerin meydana ��kar�lmas� i�in y�ntem.
MX9702863A (es) Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas.
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
TR200003467T2 (tr) Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
PE20399A1 (es) Muteina ob
DE69505191T2 (de) Mikrogel enthaltende anionische wasserdispergierbare Harzzusammensetzung und Zusammensetzung für Elektrotauchlackierung, welche diese enthält

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties